These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


138 related items for PubMed ID: 6859600

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Acid-neutralizing capacity and sodium content of antacid products from Belgium.
    Gombatz VW.
    Clin Ther; 1984; 6(2):151-4. PubMed ID: 6705010
    [Abstract] [Full Text] [Related]

  • 4. High dose of antacid (Mylanta II) reduces bioavailability of ranitidine.
    Mihaly GW, Marino AT, Webster LK, Jones DB, Louis WJ, Smallwood RA.
    Br Med J (Clin Res Ed); 1982 Oct 09; 285(6347):998-9. PubMed ID: 6289961
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antacid and formula effects on gastric acidity in infants with gastroesophageal reflux.
    Sutphen JL, Dillard VL, Pipan ME.
    Pediatrics; 1986 Jul 09; 78(1):55-7. PubMed ID: 3725503
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Determination of neutralization capacity of antacids in gastric juice].
    Halter F.
    Z Gastroenterol; 1983 Mar 09; 21 Suppl():33-40. PubMed ID: 6858409
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vitro tests overestimate in vivo neutralizing capacity of antacids in presence of food.
    Berchtold P, Reinhart WH, Niederhäuser U, Koller U, Halter F.
    Dig Dis Sci; 1985 Jun 09; 30(6):522-8. PubMed ID: 3158500
    [Abstract] [Full Text] [Related]

  • 13. Effect of proteolytic enzymes and polypeptides on the antacid activity of almagate and other antacids.
    Beneyto JE, Fábregas JL.
    Arzneimittelforschung; 1984 Jun 09; 34(10A):1357-60. PubMed ID: 6391496
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Serum and urine electrolyte behavior under therapeutic dosage of a potent magnesium and aluminum hydroxide containing antacid].
    Grünzig G, Lücker PW, Schnitker J.
    Arzneimittelforschung; 1983 Jun 09; 33(2):258-62. PubMed ID: 6682667
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of buffering capacity and acid neutralizing-pH time profile of antacids.
    Lin MS, Sun P, Yu HY.
    J Formos Med Assoc; 1998 Oct 09; 97(10):704-10. PubMed ID: 9830281
    [Abstract] [Full Text] [Related]

  • 17. Effect of antacids on the plasma concentration of phenoperidine.
    Calvey TN, Milne LA, Williams NE, Chan K, Murray GR.
    Br J Anaesth; 1983 Jun 09; 55(6):535-9. PubMed ID: 6860522
    [Abstract] [Full Text] [Related]

  • 18. Activated aluminum complex derived from solubilized antacids exhibits enhanced cytoprotective activity in the rat.
    DiJoseph JF, Borella LE, Mir GN.
    Gastroenterology; 1989 Mar 09; 96(3):730-5. PubMed ID: 2914636
    [Abstract] [Full Text] [Related]

  • 19. [Do antacids with high acid-binding capacity modify mineral metabolism?].
    Dollinger HC, Holzberg E.
    Fortschr Med Suppl; 1987 Mar 09; 19():10-4. PubMed ID: 2883095
    [No Abstract] [Full Text] [Related]

  • 20. Duration of action of an antacid in two groups of patients.
    González L, Olazábal A.
    Bol Asoc Med P R; 1980 Nov 09; 72(11):574-7. PubMed ID: 7011340
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.